NEUROASPIS PLP10 Trademark Information

Trademark by PALUPA MEDICAL LTD

Dietary supplements; Dietary supplements for the treatment and prevention of inflammatory, autoimmune, cardiovascular and neurological diseases and disorders; Nutritional supplements; Pharmaceutical preparations for for the treatment and prevention of inflammatory, autoimmune, cardiovascular and neurological diseases and disorders; Nutraceuticals for use as a dietary supplement

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 1/15/2015
First Use In Commerce: 7/9/2015
General Information
Word mark: NEUROASPIS PLP10
Status/Status Date:
REGISTERED
10/20/2020
Serial Number: 88800374
Filing Date: 2/17/2020
Registration Number: 6178327
Registration Date: 10/20/2020
Goods and Services: Dietary supplements; Dietary supplements for the treatment and prevention of inflammatory, autoimmune, cardiovascular and neurological diseases and disorders; Nutritional supplements; Pharmaceutical preparations for for the treatment and prevention of inflammatory, autoimmune, cardiovascular and neurological diseases and disorders; Nutraceuticals for use as a dietary supplement
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 8/4/2020
Last Applicant/Owner:
PALUPA MEDICAL LTD
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
REGISTERED
10/20/2020
Correspondent Search:
PATRICK MORIN is a correspondent of NEUROASPIS PLP10 trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on